"Waiting for a Vaccine vs. a Resilient Microbiome"

Excerpt below from Dr. David Marquis at Pathways to Health in Pismo Beach & link to his 8-min YouTube Video posted 5/27/2020:

"Take action and be prepared for the inevitable! No matter how distant, masked and/or safe you are, you will most likely be exposed to the COVID-19 virus at some point in time (which like all viruses that continuously mutate) or to the next virus that is guaranteed to present itself down the road. I hope you will ask yourself, is my best strategy to wait for an anticipated vaccine (knowing that all vaccines and FDA approved pharmaceuticals have the potential for adverse side effects) or should I take responsibility for my health and provide my body with the natural fuel it needs to promote a healthy microbiome? You have the freedom to choose your own path, I have chosen not to wait. Chances are, I will be exposed to COVID-19 at some point so I am committed to engaging in healthy strategies that promote a resilient microbiome capable of adapting to the unavoidable reality that we are exposed to all types of viruses, bacteria and diseases...constantly. It is simple biology. Our bodies are designed to stay well and heal when required. Reducing inflammation and strengthening your immune system is essential in supporting that design.

As many of you continue to obey stay at home and masking orders, I hope you will also take this opportunity to do your own research regarding the risks vs the benefits of those strategies. There are many studies easily accessible, read them and make up your own mind!

I encourage you to remain positive and focus on your optimal whole health to create a more resilient you, and I hope you will encourage others to do the same. Take responsibility for your health and be well."

Studies Referenced:

JAMA: Association Between Celiac Disease and Mortality Risk in a Swedish Population - https://jamanetwork.com/journals/jama/article-abstract/2764182

Frontiers in Immunology: Intestinal Microbiota Disruption Reduces Regulatory T Cells and Increases Respiratory Viral Infection Mortality Through Increased IFNγ Production https://doi.org/10.3389/fimmu.2018.01587